Proton Pump Inhibitor Use Before and After a Diagnosis of Inflammatory Bowel Disease

Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study

Systematic review with meta-analysis: environmental and dietary differences of IBD in Eastern and Western populations

Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study

Proton pump inhibitors use and risk of inflammatory bowel diseases: a meta-analysis of observational studies

Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study

Use of contraceptives and risk of inflammatory bowel disease: a nested case-control study

Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts

Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus

Proton Pump Inhibitors, H~2~ Blocker Use, and Risk of Inflammatory Bowel Disease in Children